Evonik, one of the world's leading specialty chemicals companies, is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The ...
Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to ...
What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...
After pledging earlier this year to bolster its drug substance capabilities in Central Europe, German chemical company Evonik is turning its attention to the U.S. The company is laying out $100 ...
Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd announced the commissioning of a state-of-the-art antibody–drug conjugate (ADC) GMP manufacturing facility, purpose-built and designed to ...
SHANGHAI, June 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance ...
Evonik to invest US$ 100 million to upgrade drug substance manufacturing site in Lafayette, Indiana: Essen, Germany Friday, July 10, 2026, 11:00 Hrs [IST] Evonik, one of the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results